Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
2017
1.1K+
LTM Revenue $6.0B
LTM EBITDA -$132M
$2.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Agilon Health has a last 12-month revenue of $6.0B and a last 12-month EBITDA of -$132M.
In the most recent fiscal year, Agilon Health achieved revenue of $6.1B and an EBITDA of -$218M.
Agilon Health expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Agilon Health valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $4.3B | $6.1B | XXX | XXX | XXX |
Gross Profit | $112M | $69.7M | XXX | XXX | XXX |
Gross Margin | 3% | 1% | XXX | XXX | XXX |
EBITDA | -$168M | -$218M | XXX | XXX | XXX |
EBITDA Margin | -4% | -4% | XXX | XXX | XXX |
Net Profit | -$107M | -$263M | XXX | XXX | XXX |
Net Margin | -2% | -4% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Agilon Health's stock price is $6.
Agilon Health has current market cap of $2.3B, and EV of $2.0B.
See Agilon Health trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$2.0B | $2.3B | XXX | XXX | XXX | XXX | $-0.52 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Agilon Health has market cap of $2.3B and EV of $2.0B.
Agilon Health's trades at 0.3x LTM EV/Revenue multiple, and -14.7x LTM EBITDA.
Analysts estimate Agilon Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Agilon Health and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $2.0B | XXX | XXX | XXX |
EV/Revenue | 0.3x | XXX | XXX | XXX |
EV/EBITDA | -8.9x | XXX | XXX | XXX |
P/E | -8.9x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -19.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAgilon Health's NTM/LTM revenue growth is 3%
Agilon Health's revenue per employee for the last fiscal year averaged $5.6M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, Agilon Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Agilon Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Agilon Health and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 40% | XXX | XXX | XXX | XXX |
EBITDA Margin | -4% | XXX | XXX | XXX | XXX |
EBITDA Growth | 30% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | -1% | XXX | XXX | XXX | XXX |
Revenue per Employee | $5.6M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 5% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Agilon Health acquired XXX companies to date.
Last acquisition by Agilon Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Agilon Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Agilon Health founded? | Agilon Health was founded in 2017. |
Where is Agilon Health headquartered? | Agilon Health is headquartered in United States of America. |
How many employees does Agilon Health have? | As of today, Agilon Health has 1.1K+ employees. |
Who is the CEO of Agilon Health? | Agilon Health's CEO is Mr. Steven J. Sell. |
Is Agilon Health publicy listed? | Yes, Agilon Health is a public company listed on NYS. |
What is the stock symbol of Agilon Health? | Agilon Health trades under AGL ticker. |
When did Agilon Health go public? | Agilon Health went public in 2021. |
Who are competitors of Agilon Health? | Similar companies to Agilon Health include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
What is the current market cap of Agilon Health? | Agilon Health's current market cap is $2.3B |
What is the current revenue of Agilon Health? | Agilon Health's last 12-month revenue is $6.0B. |
What is the current EBITDA of Agilon Health? | Agilon Health's last 12-month EBITDA is -$132M. |
What is the current EV/Revenue multiple of Agilon Health? | Current revenue multiple of Agilon Health is 0.3x. |
What is the current EV/EBITDA multiple of Agilon Health? | Current EBITDA multiple of Agilon Health is -14.7x. |
What is the current revenue growth of Agilon Health? | Agilon Health revenue growth between 2023 and 2024 was 40%. |
Is Agilon Health profitable? | Yes, Agilon Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.